|
[1]
|
Lagunas-Rangel, F.A. (2025) METTL3 in Colorectal Cancer: Molecular Insights and Clinical Implications. Molecular Biology Reports, 53, Article No. 98. [Google Scholar] [CrossRef]
|
|
[2]
|
Jiang, T., Jiang, N., Chen, X. and Xiong, Z. (2025) The Role of NSUN Family Genes in m5C Methylation and Diseases. Biomedicines, 13, Article 2951. [Google Scholar] [CrossRef]
|
|
[3]
|
Wang, H., Ge, L., Li, J., Zhong, K., Li, S., Ma, N., et al. (2026) NAT10 Triggers Colorectal Cancer Progression via Promoting PPAN-Regulated DNA Damage Repair. Oncogene, 45, 558-576. [Google Scholar] [CrossRef]
|
|
[4]
|
Zhao, Y., Sun, H., Li, W., Ye, C., Dou, X., Peng, Y., et al. (2025) Pseudouridylation of 7SK by PUS7 Regulates Pol II Transcription Elongation. Nature Communications, 16, Article No. 9595. [Google Scholar] [CrossRef]
|
|
[5]
|
Yang, Q., Boyer, T.G. and Al-Hendy, A. (2025) Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential. Cells, 14, Article 1380. [Google Scholar] [CrossRef]
|
|
[6]
|
Hu, J., Zhu, S., He, X., Cen, B., Xu, Z., Han, F., et al. (2026) ALKBH5 Enhances Cadmium-Induced Stemness Enrichment and Proliferation of Colon Cancer Cells via m6A-Dependent Regulation of AXIN2 and Activation of Wnt/β-Catenin Signaling. Chemico-Biological Interactions, 425, Article 111905. [Google Scholar] [CrossRef]
|
|
[7]
|
Niu, F., Ren, Y., Li, Y., Li, Z., Li, Z., Wang, J., et al. (2026) RNA-Binding Protein GIGYF2 Promotes Colorectal Cancer Progression through Activation of the METTL3/SERP1/STAT3 Axis in an m6A-IGF2BP2-Dependent Manner. Biochemical Pharmacology, 243, Article 117446. [Google Scholar] [CrossRef]
|
|
[8]
|
Lu, Q., Lv, X., Wang, J., Xia, B., Yan, H., Wang, Z., et al. (2025) Methylation-Mediated LncRNA CRAT40 Promotes Colorectal Cancer Progression by Recruiting YBX1 to Initiate Rela Transcription. International Journal of Biological Sciences, 21, 4834-4850. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Li, J., Luo, Q., Lu, M., Lu, C., Xu, C., Ding, J., et al. (2025) METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. International Journal of Biological Sciences, 21, 4782-4797. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wang, J., Dai, X., Liu, H., et al. (2025) HPD is an m6A Methyltransferase that Protects Colorectal Cancer Cells from Ferroptotic Cell Death by m6A Methylating SLC7A11/GPX4. Advanced Science, 2025, e08541.
|
|
[11]
|
Xu, J., Zhang, J., Li, R., Chen, S., Duan, C., Ma, X., et al. (2026) FTO-Mediated m6A Demethylation of CSF3 Suppresses Netosis via Downregulation of RLN2 Expression in Colorectal Cancer. Cell Biology and Toxicology, 42, Article No. 4. [Google Scholar] [CrossRef]
|
|
[12]
|
Zhou, H., Chen, H., Liu, W., Liang, C., Wang, S., Yuan, K., et al. (2025) Targeting of the M6a Eraser ALKBH5 Suppresses Stemness and Chemoresistance of Colorectal Cancer. Nature Communications, 17, Article No. 803. [Google Scholar] [CrossRef]
|
|
[13]
|
Cheung, H., Chen, H., Chen, D., Zhou, H., Liang, C., Liu, W., et al. (2025) YTHDF1 Targets the Chemotherapy Response by Suppressing NOTCH1-Induced Stemness in Colorectal Cancer. Signal Transduction and Targeted Therapy, 10, Article No. 409. [Google Scholar] [CrossRef]
|
|
[14]
|
Wen, J., Shen, M., Zhao, H., Liu, L., Hua, Q., Zhao, X., et al. (2025) Deacetylation of ACLY Mediates RNA m6A-Modification of NOXA and Promotes Chemoresistance of Colorectal Cancer. Advanced Science, 12, e03323. [Google Scholar] [CrossRef]
|
|
[15]
|
Meng, H., Jalal, M., Wang, H., Wang, Y., Feng, Y., Zheng, P., et al. (2026) 17-AAG Promotes the Degradation of HSP90 Client METTL3 to Suppress MYC RNA m6A Modification and Expression in Colorectal Cancer. International Journal of Biological Macromolecules, 337, Article 149421. [Google Scholar] [CrossRef]
|
|
[16]
|
Zhu, J.F., Guo, D.P., Lv, H.N., et al. (2025) Histone Lactylation‐Mediated Up‐Regulation of IGF2BP2 Enhances Ferroptosis Resistance via Nrf2 in Colorectal Cancer. Clinical and Translational Medicine, 15, e70551. [Google Scholar] [CrossRef]
|
|
[17]
|
Li, M., Zha, X., Gao, Z., Zhao, Y., Ma, J., Tian, J., et al. (2025) Downregulated Smad3 Signaling Impairs the Maturation of MO-MDSC in Colorectal Cancer. Cell Death & Disease, 16, Article No. 880. [Google Scholar] [CrossRef]
|
|
[18]
|
Tan, J., Yu, J., Hou, D., Xie, Y., Lai, D., Zheng, F., et al. (2025) Extracellular Vesicle-Packaged circTAX1BP1 from Cancer-Associated Fibroblasts Regulates RNA m6A Modification through Lactylation of VIRMA in Colorectal Cancer Cells. Advanced Science, 12, e14008. [Google Scholar] [CrossRef]
|
|
[19]
|
Gong, T., Rai, S.K., Zhu, Y., et al. (2025) Integrative Epitranscriptomic and Transcriptomic Characterization in Human Colorectal Cancer. Journal of Advanced Research. (In Press) [Google Scholar] [CrossRef]
|
|
[20]
|
Wang, Q., Jiang, X., Yuan, Y. and Li, C. (2025) METTL16 Emerges as a Pivotal Epitranscriptomic Regulator, Linking RNA Modification, Tumor Progression, and Immune Modulation. Frontiers in Immunology, 16, Article 1706971. [Google Scholar] [CrossRef]
|
|
[21]
|
Wang, G., Ma, Q., Zhu, N., Yan, Y., Zhong, C., Hong, X., et al. (2025) Long Non-Coding Rnas Promote Colorectal Cancer Development through Other Epigenetic Modifications. Gastroenterology Report, 13, goaf081. [Google Scholar] [CrossRef]
|
|
[22]
|
Qian, S., Song, H., Huang, L., Hua, H., Zhang, X., Li, Z., et al. (2025) DNA, RNA, and Histone Methylation Regulation Enzymes and Their Crosstalk in Colorectal Carcinogenesis and Progression: A Review of Molecular Mechanisms, Clinical Implications, and Future Perspectives. Cellular & Molecular Biology Letters, 30, Article No. 142. [Google Scholar] [CrossRef]
|
|
[23]
|
Cheng, X., Guo, J., Cao, H., Bi, H., Dong, S., Wang, H., et al. (2025) A Highly Sensitive Magnetic Separation-Assisted Electrochemical Sensor for Detection of m6A-MicroRNA-17-5p Based on Rolling Circle Amplification and N3-Kethoxal Labeling Strategy at LIG Electrodes. Analytica Chimica Acta, 1377, Article 344655. [Google Scholar] [CrossRef]
|
|
[24]
|
Xi, Y., Liu, L., Kim, J., Zhang, M., Wang, X., Abdirassil, A., et al. (2026) Targeting ADAR1-Mediated RNA Editing Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Enhancing HSC-Intrinsic Innate Immunity. Gut, 2026, gutjnl-2025-335942. [Google Scholar] [CrossRef]
|
|
[25]
|
Li, H., Guo, Z., Zou, Y., Zhang, J., Shi, J., Fu, X., et al. (2026) Tumor Extracellular Vesicles LncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis. Advanced Science, 2026, e19490. [Google Scholar] [CrossRef]
|
|
[26]
|
Xi, C., Gao, Y., Jiang, H., Bian, Y., Yu, C., Chen, Z., et al. (2026) The Novel Roles of RNA 5-Methylcytosine Modification in Gastrointestinal Tract Cancers. Critical Reviews in Oncology/Hematology, 219, Article 105140. [Google Scholar] [CrossRef]
|
|
[27]
|
Lee, K.H., Sears, T.J., Zanetti, M., et al. (2025) NeoPrecis: Enhancing Immunotherapy Response Prediction through Integration of Qualified Immunogenicity and Clonality-Aware Neoantigen Landscapes. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zecchin, C., Schalkwijk, S., Pouliquen, I.J., et al. (2026) Straight to Phase III: Model-Informed Approach Speeds Depemokimab Clinical Development in Interleukin-5-Driven Diseases. Clinical Pharmacology and Therapeutics. [Google Scholar] [CrossRef]
|
|
[29]
|
Ingber, D.E. (2026) Challenges and Opportunities for Human Organ Chips in FDA Assessments and Pharma Pipelines. Cell Stem Cell, 33, 176-183. [Google Scholar] [CrossRef]
|
|
[30]
|
Ni, W., Xu, Y., Zhang, M., Li, Y., Huang, P., Li, Z., et al. (2025) Lipid Deposition Promotes YTHDF3-Mediated m6A Modification of PPARα to Facilitate Liver Metastasis of Colorectal Cancer. Protein & Cell, 2025, pwaf092. [Google Scholar] [CrossRef]
|